Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-20 Sale | 2024-08-22 8:01 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,000 | $280 | $4,200,000 | 76,200 (Indirect Direct) | View |
2024-08-12 Sale | 2024-08-14 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 22,025 | $270.99 | $5,968,516 | 15,610 (Indirect Direct) | View |
2024-08-06 Sale | 2024-08-08 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 20,250 | $262 | $5,305,586 | 3,636 (Indirect Direct) | View |
2024-08-01 Sale | 2024-08-02 8:01 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,148 | $270 | $4,089,960 | 91,200 (Indirect Direct) | View |
2024-07-11 Sale | 2024-07-12 8:02 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 7,093 | $261 | $1,851,273 | 73,848 (Indirect Direct) | View |
2024-06-25 Sale | 2024-06-27 4:04 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $240 | $2,040,000 | 11,186 (Direct) | View |
2024-06-24 Sale | 2024-06-26 4:28 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 32,450 | $220.69 | $7,161,360 | 43,086 (Indirect Direct) | View |
2024-06-25 Sale | 2024-06-26 4:28 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 2,103 | $230.99 | $485,773 | 16,290 (Indirect Direct) | View |
2024-06-25 Sale | 2024-06-26 4:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 8,301 | $230.99 | $1,917,475 | 80,941 (Indirect Direct) | View |
2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,605 | $231 | $370,747 | 28,949 (Indirect Direct) | View |
2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,605 | $231 | $370,747 | 11,660 (Direct) | View |
2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 1,198 | $230.99 | $276,731 | 14,718 (Indirect Direct) | View |
2024-05-29 Sale | 2024-05-31 7:00 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 21,700 | $148.6 | $3,224,546 | 8,436 (Direct) | View |
2024-02-29 Sale | 2024-03-01 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 30,000 | $151.34 | $4,540,071 | 266,899 (Indirect Direct) | View |
2024-02-28 Sale | 2024-02-29 4:18 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 501 | $155.3 | $77,805 | 8,569 (Direct) | View |
2024-02-28 Sale | 2024-02-29 4:18 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 574 | $155.3 | $89,145 | 23,351 (Indirect Direct) | View |
2024-02-28 Sale | 2024-02-29 4:18 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 2,932 | $155.31 | $455,357 | 60,377 (Indirect Direct) | View |
2024-02-28 Sale | 2024-02-29 4:17 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 574 | $155.3 | $89,145 | 13,163 (Indirect Direct) | View |
2024-02-28 Sale | 2024-02-29 4:16 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary | 329 | $155.3 | $51,094 | 5,887 (Direct) | View |
2024-02-16 Sale | 2024-02-20 4:09 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,308 | $148.06 | $193,666 | 8,013 (Indirect Direct) | View |
2024-02-16 Sale | 2024-02-20 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,007 | $148.06 | $149,099 | 18,201 (Indirect Direct) | View |
2024-02-16 Sale | 2024-02-20 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,009 | $148.06 | $149,397 | 4,070 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-01 Option Award | 2024-10-03 4:11 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary | 7,245 | $0 | 7,245 (Direct) | View |
2024-08-20 Exercise | 2024-08-22 8:01 pm | N/A 2029-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,000 | $0 | 76,200 (Direct) | View |
2024-08-20 Exercise | 2024-08-22 8:01 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,000 | $85 | 76,200 (Direct) | View |
2024-08-12 Exercise | 2024-08-14 4:12 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 6,667 | $97.72 | 15,610 (Direct) | View |
2024-08-12 Exercise | 2024-08-14 4:12 pm | N/A 2029-02-28 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 20,725 | $0 | 15,610 (Direct) | View |
2024-08-12 Exercise | 2024-08-14 4:12 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 14,058 | $85 | 15,610 (Direct) | View |
2024-08-06 Exercise | 2024-08-08 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 11,250 | $131.21 | 3,636 (Direct) | View |
2024-08-06 Exercise | 2024-08-08 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 9,000 | $105.26 | 3,636 (Direct) | View |
2024-08-06 Exercise | 2024-08-08 4:10 pm | 2019-06-20 2028-06-19 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 20,250 | $0 | 3,636 (Direct) | View |
2024-08-01 Exercise | 2024-08-02 8:01 pm | N/A 2029-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,148 | $0 | 91,200 (Direct) | View |
2024-08-01 Exercise | 2024-08-02 8:01 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,148 | $85 | 91,200 (Direct) | View |
2024-06-25 Exercise | 2024-06-27 4:04 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $131.21 | 11,186 (Direct) | View |
2024-06-25 Exercise | 2024-06-27 4:04 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $0 | 11,186 (Direct) | View |
2024-06-24 Exercise | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,470 | $71.99 | 43,086 (Direct) | View |
2024-06-24 Exercise | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,420 | $70.2 | 43,086 (Direct) | View |
2024-06-24 Exercise | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 17,560 | $88.95 | 43,086 (Direct) | View |
2024-06-24 Exercise | 2024-06-26 4:28 pm | 2017-06-03 2026-06-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 32,450 | $0 | 43,086 (Direct) | View |
2024-06-24 Option Award | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,295 | $0 | 16,290 (Direct) | View |
2024-06-24 Option Award | 2024-06-26 4:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 16,953 | $0 | 80,941 (Direct) | View |
2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,278 | $0 | 28,949 (Direct) | View |
2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,278 | $0 | 11,660 (Direct) | View |
2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,498 | $0 | 14,718 (Direct) | View |
2024-05-29 Exercise | 2024-05-31 7:00 pm | N/A 2024-07-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 30,000 | $0 | 8,436 (Direct) | View |
2024-05-29 Exercise | 2024-05-31 7:00 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 30,000 | $66.83 | 8,436 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:11 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:10 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | KELLOGG PETER N Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:09 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Bertozzi Carolyn R Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:08 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:07 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:06 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:06 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:05 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:04 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:03 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 5,228 | $0 | 5,228 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:02 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 5,228 | $0 | 5,228 (Direct) | View |
Ownership | 2024-03-28 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 0 | $0 | 124,620 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 4:22 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 14,030 | $0 | 19,266 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 4:21 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 14,030 | $0 | 23,377 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 4:21 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 22,859 | $0 | 42,394 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 4:20 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 70,148 | $0 | 118,683 (Direct) | View |
2024-02-29 Exercise | 2024-03-01 4:12 pm | 2015-06-05 2024-06-04 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 30,000 | $0 | 266,899 (Direct) | View |
2024-02-29 Exercise | 2024-03-01 4:12 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 30,000 | $59.25 | 266,899 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:18 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,667 | $0 | 8,569 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:18 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 23,351 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:18 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,921 | $0 | 60,377 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,908 | $0 | 13,163 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:16 pm | N/A 2026-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary | 878 | $0 | 5,887 (Direct) | View |
2024-02-15 Option Award | 2024-02-20 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,295 | $0 | 8,013 (Direct) | View |
2024-02-15 Option Award | 2024-02-20 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,278 | $0 | 18,201 (Direct) | View |
2024-02-15 Option Award | 2024-02-20 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,278 | $0 | 4,070 (Direct) | View |